CAI
CAI clinical trials: Caris Life Sciences, Inc.
Every trial on ClinicalTrials.gov where Caris Life Sciences, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 4
- Trials linked
- 0
- As lead sponsor
- 4
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
CAI on the catalyst calendar · CAI registry changes
- Primary completion Jun 2025Sponsor estimateNo phase registeredNCT03870620Metastatic Breast Cancer in AustriaArbeitsgemeinschaft medikamentoese Tumortherapie · Breast Cancer
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2020ActualPhase 2NCT03834220Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)Debiopharm International SA · Solid TumorTerminatedCAICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 1, 2023Sponsor estimateNo phase registeredNCT05692466Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting ("DINOSAur")Glendale Adventist Medical Center d/b/a Adventist Health Glendale · Stage III Solid TumorsUnknown statusCAICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2018ActualPhase 2NCT02967770Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic CancerGeorgetown University · Metastatic Pancreatic CancerWithdrawnGHCollaboratorCAICollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 4 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner